Authors:
DALSGAARD I
GUDMUNDSDOTTIR BK
HELGASON S
HOIE S
THORESEN OF
WICHARDT UP
WIKLUND T
Citation: I. Dalsgaard et al., IDENTIFICATION OF ATYPICAL AEROMONAS-SALMONICIDA - INTER-LABORATORY EVALUATION AND HARMONIZATION OF METHODS, Journal of applied microbiology, 84(6), 1998, pp. 999-1006
Authors:
JANES RJ
MUHONEN T
KARJALAINEN UP
WIKLUND T
Citation: Rj. Janes et al., URINARY 5-HYDROXYINDOLEACETIC ACID (5-HIAA) EXCRETION DURING MULTIPLE-DAY HIGH-DOSE CHEMOTHERAPY, European journal of cancer, 34(1), 1998, pp. 196-198
Authors:
BERGH J
WIKLUND T
ERIKSTEIN B
FORNANDER T
BENGTSSON NO
MALMSTROM P
KELLOKUMPULEHTINEN P
ANKER G
BENNMARKER H
WILKING N
Citation: J. Bergh et al., DOSAGE OF ADJUVANT G-CSF (FILGRASTIM) SUPPORTED FEC POLYCHEMOTHERAPY BASED ON EQUIVALENT HEMATOLOGICAL TOXICITY IN HIGH-RISK BREAST-CANCER PATIENTS, Annals of oncology, 9(4), 1998, pp. 403-411
Citation: T. Wiklund et I. Dalsgaard, OCCURRENCE AND SIGNIFICANCE OF ATYPICAL AEROMONAS-SALMONICIDA IN NON-SALMONID AND SALMONID FISH SPECIES - A REVIEW, Diseases of aquatic organisms, 32(1), 1998, pp. 49-69
Authors:
TRAVIS LB
CURTIS RE
STORM H
HALL P
HOLOWATY E
VANLEEUWEN FE
KOHLER BA
PUKKALA E
LYNCH CF
ANDERSSON M
BERGFELDT K
CLARKE EA
WIKLUND T
STOTER G
GOSPODAROWICZ M
STURGEON J
FRAUMENI JF
BOICE JD
Citation: Lb. Travis et al., RISK OF 2ND MALIGNANT NEOPLASMS AMONG LONG-TERM SURVIVORS OF TESTICULAR CANCER, Journal of the National Cancer Institute, 89(19), 1997, pp. 1429-1439
Authors:
WIKLUND T
SAETER G
STRANDER H
ALVEGARD T
BLOMQVIST C
Citation: T. Wiklund et al., THE OUTCOME OF ADVANCED SOFT-TISSUE SARCOMA PATIENTS WITH COMPLETE TUMOR-REGRESSION AFTER EITHER CHEMOTHERAPY ALONE OR CHEMOTHERAPY PLUS SURGERY - THE SCANDINAVIAN SARCOMA GROUP EXPERIENCE, European journal of cancer, 33(3), 1997, pp. 357-361
Authors:
KAJANTI M
BLOMQVIST C
LEHTONEN H
KOURI M
WIKLUND T
HOLSTI LR
Citation: M. Kajanti et al., BIWEEKLY DOSE-ESCALATION IN CURATIVE ACCELERATED HYPERFRACTIONATION FOR ADVANCED HEAD AND NECK-CANCER - A FEASIBILITY STUDY, International journal of radiation oncology, biology, physics, 39(4), 1997, pp. 837-840
Authors:
ILVESKOSKI I
SAARINEN UM
WIKLUND T
SIPILA I
MAKIPERNAA A
PERKKIO M
LANNING M
SALMI TT
PIHKO H
Citation: I. Ilveskoski et al., GROWTH IMPAIRMENT AND GROWTH-HORMONE THERAPY IN CHILDREN TREATED FOR MALIGNANT BRAIN-TUMORS, European journal of pediatrics, 156(10), 1997, pp. 764-769
Authors:
SZYMANSKA J
VIROLAINEN M
TARKKANEN M
WIKLUND T
ASKOSELJAVAARA S
TUKIAINEN E
ELOMAA I
BLOMQVIST C
KNUUTILA S
Citation: J. Szymanska et al., OVERREPRESENTATION OF 1Q21-23 AND 12Q13-21 IN LIPOMA-LIKE LIPOSARCOMAS BUT NOT IN BENIGN LIPOMAS - A COMPARATIVE GENOMIC HYBRIDIZATION STUDY, Cancer genetics and cytogenetics, 99(1), 1997, pp. 14-18
Authors:
LARRAMENDY ML
TARKKANEN M
BLOMQVIST C
VIROLAINEN M
WIKLUND T
ASKOSELJAVAARA S
ELOMAA I
KNUUTILA S
Citation: Ml. Larramendy et al., COMPARATIVE GENOMIC HYBRIDIZATION OF MALIGNANT FIBROUS HISTIOCYTOMA REVEALS A NOVEL PROGNOSTIC MARKER, The American journal of pathology, 151(4), 1997, pp. 1153-1161
Authors:
SZYMANSKA J
TARKKANEN M
WIKLUND T
VIROLAINEN M
BLOMQVIST C
ASKOSELJAVAARA S
TUKIAINEN E
ELOMAA I
KNUUTILA S
Citation: J. Szymanska et al., GAINS AND LOSSES OF DNA-SEQUENCES IN LIPOSARCOMAS EVALUATED BY COMPARATIVE GENOMIC HYBRIDIZATION, Genes, chromosomes & cancer, 15(2), 1996, pp. 89-94
Authors:
WIKLUND T
HUUHTANEN R
BLOMQVIST C
TUKIAINEN E
VIROLAINEN M
VIRKKUNEN P
ASKOSELJAVAARA S
BJORKENHEIM JM
ELOMAA I
Citation: T. Wiklund et al., THE IMPORTANCE OF A MULTIDISCIPLINARY GROUP IN THE TREATMENT OF SOFT-TISSUE SARCOMAS, European journal of cancer, 32A(2), 1996, pp. 269-273
Citation: T. Wiklund et al., GONADAL IMPAIRMENT IN ROACH RUTILUS-RUTILUS FROM FINNISH COASTAL AREAS OF THE NORTHERN BALTIC SEA, Diseases of aquatic organisms, 26(3), 1996, pp. 163-171
Authors:
ILVESKOSKI I
PIHKO H
WIKLUND T
LAMMINRANTA S
PERKKIO M
MAKIPERNAA A
SALMI TT
LANNING M
SAARINEN UM
Citation: I. Ilveskoski et al., NEUROPSYCHOLOGIC LATE EFFECTS IN CHILDREN WITH MALIGNANT BRAIN-TUMORSTREATED WITH SURGERY, RADIOTHERAPY AND 8-IN-1 CHEMOTHERAPY, Neuropediatrics, 27(3), 1996, pp. 124-129
Authors:
SZYMANSKA J
TARKKANEN M
WIKLUND T
VIROLAINEN M
BLOMQVIST C
ASKOSELJAVAARA S
TUKIAINEN E
ELOMAA I
KNUUTILA S
Citation: J. Szymanska et al., CYTOGENETIC STUDY OF EXTRASKELETAL MESENCHYMAL CHONDROSARCOMA - A CASE-REPORT, Cancer genetics and cytogenetics, 86(2), 1996, pp. 170-173
Authors:
ILVESKOSKI I
SAARINEN UM
WIKLUND T
PERKKIO M
SALMI TT
LANNING M
MAKIPERNAA A
PIHKO H
Citation: I. Ilveskoski et al., OTOTOXICITY IN CHILDREN WITH MALIGNANT BRAIN-TUMORS TREATED WITH THE 8-IN-1 CHEMOTHERAPY PROTOCOL, Medical and pediatric oncology, 27(1), 1996, pp. 26-31
Citation: T. Wiklund et G. Bylund, FIN ABNORMALITIES OF PIKEPERCH IN COASTAL AREAS OFF THE FINNISH SOUTHCOAST, Journal of Fish Biology, 48(4), 1996, pp. 652-657
Authors:
BLOMQVIST C
HUUHTANEN R
PAN Y
WIKLUND T
TARKKANEN M
VIROLAINEN M
TRIBUKAIT B
Citation: C. Blomqvist et al., GROWTH-RATE OF LUNG METASTASES AND S-PHASE FRACTION AS DETERMINED BY FLOW-CYTOMETRY FROM THE PRIMARY TUMOR IN 25 PATIENTS WITH BONE OR SOFT-TISSUE SARCOMAS, British Journal of Cancer, 73(12), 1996, pp. 1556-1559
Authors:
WIKLUND T
BLOMQVIST C
RISTELI L
RISTELI J
KARAHARJU E
ELOMAA I
Citation: T. Wiklund et al., TYPE-I AND TYPE-III COLLAGEN METABOLITES IN ADULT OSTEOSARCOMA PATIENTS, British Journal of Cancer, 73(1), 1996, pp. 106-109
Authors:
BLOMQVIST C
WIKLUND T
PAJUNEN M
VIROLAINEN M
ELOMAA I
Citation: C. Blomqvist et al., ORAL TROFOSFAMIDE - AN ACTIVE-DRUG IN THE TREATMENT OF SOFT-TISSUE SARCOMA, Cancer chemotherapy and pharmacology, 36(3), 1995, pp. 263-265
Citation: T. Wiklund, SURVIVAL OF ATYPICAL AEROMONAS-SALMONICIDA IN WATER AND SEDIMENT MICROCOSMS OF DIFFERENT SALINITIES AND TEMPERATURES, Diseases of aquatic organisms, 21(2), 1995, pp. 137-143
Citation: T. Wiklund, VIRULENCE OF ATYPICAL AEROMONAS-SALMONICIDA ISOLATED FROM ULCERATED FLOUNDER PLATICHTHYS-FLESUS, Diseases of aquatic organisms, 21(2), 1995, pp. 145-150